# SOX6

## Overview
The SOX6 gene encodes the SRY-box transcription factor 6, a member of the SOXD subgroup of transcription factors, which is characterized by a high-mobility group (HMG) box DNA-binding domain. This protein plays a pivotal role in the regulation of gene expression during the differentiation and development of various cell types, including skeletal muscle, cardiac muscle, and the central nervous system (Saleem2020Emerging; Hagiwara2011Sox6). SOX6 functions primarily as a transcriptional regulator, capable of both activating and repressing target genes, and is involved in critical biological processes such as muscle fiber type differentiation, neuronal and glial cell development, and erythropoiesis (An2011Genomewide; Hagiwara2011Sox6). The protein's ability to form complexes with other transcription factors, such as SOX5 and SOX9, underscores its versatile regulatory roles in different cellular contexts (Hagiwara2011Sox6). Clinically, SOX6 is implicated in various diseases, including its role as a tumor suppressor in several cancers and its involvement in skeletal disorders, highlighting its significance in both normal physiology and disease states (Smits2001The; Barbarani2019SOX6).

## Structure
The SOX6 protein is a member of the SOXD subgroup of transcription factors, characterized by a high-mobility group (HMG) box DNA-binding domain located in the C-terminal region, which is common among SOX proteins (Saleem2020Emerging). The primary structure of SOX6 includes two coiled-coil domains in the N-terminal region, which are crucial for protein-protein interactions and dimerization. These domains contain leucine zipper (LZ) and glutamine-rich (Q-box) motifs, facilitating interactions with other proteins and cofactors (Saleem2020Emerging; Hagiwara2011Sox6).

SOX6 exists in multiple isoforms, such as Sox6A, Sox6B, Sox6C, and Sox6D, resulting from alternative splicing. These isoforms differ in specific segments, affecting the protein's structure and function (Murakami2001SOX6). The coiled-coil domains are essential for the quaternary structure, allowing SOX6 to form homo- or heterodimers with other SOX proteins, such as Sox5, enhancing its DNA-binding efficiency (Lefebvre1998A; Saleem2020Emerging).

The protein's tertiary structure is not detailed in the context, but the presence of coiled-coil domains and the HMG box suggests a complex folding pattern necessary for its role as a transcription factor. SOX6 can undergo post-translational modifications, such as phosphorylation, which may influence its activity and interactions (Hagiwara2011Sox6).

## Function
The SOX6 gene encodes a transcription factor that plays a critical role in the differentiation and development of various cell types in humans. It is involved in the regulation of gene expression during the transition from progenitor cells to mature cells, influencing processes such as cell proliferation, differentiation, and terminal maturation (Saleem2020Emerging; Hagiwara2011Sox6). SOX6 is active in the nucleus, where it binds to DNA sequences with an AACAAT motif, functioning in both transcriptional activation and repression (Saleem2020Emerging).

In skeletal muscle, SOX6 acts as a transcriptional suppressor of slow fiber-specific genes, influencing muscle fiber type differentiation and ensuring proper muscle development (An2011Genomewide). It is also involved in the regulation of cardiac muscle development, where its expression is modulated by microRNAs such as miR-208 and miR-499 (An2011Genomewide; Saleem2020Emerging).

SOX6 plays a significant role in the central nervous system by regulating the differentiation of neurons and glial cells, particularly in oligodendrocyte development, where it prevents premature cell cycle exit (Hagiwara2011Sox6). It also contributes to erythropoiesis by regulating the survival and maturation of red blood cells (Hagiwara2011Sox6).

## Clinical Significance
The SOX6 gene has been implicated in various diseases due to mutations, altered expression levels, or changes in its interactions. In the context of Kashin-Beck disease (KBD), specific polymorphisms in the SOX6 gene, such as rs7928675 and rs10832681, are associated with a reduced risk of developing the disease in the Chinese Han population. These findings suggest that certain genetic variations in SOX6 may offer protective effects against KBD (He2024Association).

In cancer, SOX6 often acts as a tumor suppressor. Its expression is frequently downregulated in various cancers, including esophageal squamous cell carcinoma, hepatocarcinoma, ovarian cancer, pancreatic cancer, and colorectal cancer. This downregulation is linked to poor prognosis, while overexpression can mitigate malignant phenotypes (Barbarani2019SOX6). In acute myeloid leukemia (AML), low SOX6 expression is associated with more aggressive disease features and poorer prognosis, making it a potential biomarker for risk stratification and prognosis prediction (Li2022Clinical).

In skeletal development, SOX6, along with Sox5, is essential for cartilage formation. Mutations in these genes can lead to severe chondrodysplasia, highlighting their critical role in skeletal disorders (Smits2001The).

## Interactions
SOX6 is involved in various protein-protein and protein-DNA interactions that are crucial for its function as a transcription factor. It interacts with CtBP2, a known transcriptional co-repressor, to repress transcription from the Fgf-3 promoter. This interaction is mediated by a specific amino acid sequence, PLNLSS, in SOX6, and is essential for the formation of a repressive complex (Murakami2001SOX6; Bernard2010Acquisition). SOX6 also forms complexes with other transcription factors such as SOX5 and SOX9, which are important for chondrogenesis. These interactions are facilitated by the coiled-coil domains of SOX6, allowing it to dimerize with other SOX proteins (Bernard2010Acquisition; Hagiwara2011Sox6).

In the context of erythropoiesis, SOX6 binds directly to the ey promoter, repressing its expression. This binding involves two Sox/Sox6 consensus sites, which are critical for its repressive function (Yi2006Sox6). SOX6 also interacts with the Solt protein, enhancing transcriptional activation in the presence of Ca2+/calmodulin-dependent protein kinase IV, indicating its role in testis-specific gene expression (Yamashita2000Characterization). These interactions highlight the versatile regulatory roles of SOX6 in different cellular contexts.


## References


[1. (Bernard2010Acquisition) Pascal Bernard and Vincent R. Harley. Acquisition of sox transcription factor specificity through protein–protein interaction, modulation of wnt signalling and post-translational modification. The International Journal of Biochemistry &amp; Cell Biology, 42(3):400–410, March 2010. URL: http://dx.doi.org/10.1016/j.biocel.2009.10.017, doi:10.1016/j.biocel.2009.10.017. This article has 72 citations.](https://doi.org/10.1016/j.biocel.2009.10.017)

[2. (Lefebvre1998A) V. Lefebvre. A new long form of sox5 (l-sox5), sox6 and sox9 are coexpressed in chondrogenesis and cooperatively activate the type ii collagen gene. The EMBO Journal, 17(19):5718–5733, October 1998. URL: http://dx.doi.org/10.1093/emboj/17.19.5718, doi:10.1093/emboj/17.19.5718. This article has 632 citations.](https://doi.org/10.1093/emboj/17.19.5718)

[3. (An2011Genomewide) Chung-Il An, Yao Dong, and Nobuko Hagiwara. Genome-wide mapping of sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by sox6. BMC Developmental Biology, October 2011. URL: http://dx.doi.org/10.1186/1471-213x-11-59, doi:10.1186/1471-213x-11-59. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-213x-11-59)

[4. (Hagiwara2011Sox6) Nobuko Hagiwara. Sox6, jack of all trades: a versatile regulatory protein in vertebrate development. Developmental Dynamics, 240(6):1311–1321, April 2011. URL: http://dx.doi.org/10.1002/dvdy.22639, doi:10.1002/dvdy.22639. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.22639)

[5. (Yi2006Sox6) Zanhua Yi, Orit Cohen-Barak, Nobuko Hagiwara, Paul D Kingsley, Deborah A Fuchs, Drew T Erickson, Elliot M Epner, James Palis, and Murray H Brilliant. Sox6 directly silences epsilon globin expression in definitive erythropoiesis. PLoS Genetics, 2(2):e14, February 2006. URL: http://dx.doi.org/10.1371/journal.pgen.0020014, doi:10.1371/journal.pgen.0020014. This article has 89 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.0020014)

[6. (Smits2001The) Patrick Smits, Ping Li, Jennifer Mandel, Zhaoping Zhang, Jian Ming Deng, Richard R Behringer, Benoit de Crombrugghe, and Véronique Lefebvre. The transcription factors l-sox5 and sox6 are essential for cartilage formation. Developmental Cell, 1(2):277–290, August 2001. URL: http://dx.doi.org/10.1016/s1534-5807(01)00003-x, doi:10.1016/s1534-5807(01)00003-x. This article has 485 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s1534-5807(01)00003-x)

[7. (Saleem2020Emerging) Mohammad Saleem, Pierina Barturen‐Larrea, and Jose A. Gomez. Emerging roles of sox6 in the renal and cardiovascular system. Physiological Reports, November 2020. URL: http://dx.doi.org/10.14814/phy2.14604, doi:10.14814/phy2.14604. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.14814/phy2.14604)

[8. (Barbarani2019SOX6) Gloria Barbarani, Cristina Fugazza, Silvia M. L. Barabino, and Antonella E. Ronchi. Sox6 blocks the proliferation of bcr-abl1+ and jak2v617f+ leukemic cells. Scientific Reports, March 2019. URL: http://dx.doi.org/10.1038/s41598-019-39926-4, doi:10.1038/s41598-019-39926-4. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-39926-4)

[9. (He2024Association) Na He, Aiwen Hong, Kun Zhao, Zhefan Zhang, Shengli Wang, and Yaofei Jia. Association of sox6 gene polymorphisms with kashin-beck disease risk in the chinese han population. Open Medicine, January 2024. URL: http://dx.doi.org/10.1515/med-2023-0883, doi:10.1515/med-2023-0883. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/med-2023-0883)

[10. (Murakami2001SOX6) A. Murakami. Sox6 binds ctbp2 to repress transcription from the fgf-3 promoter. Nucleic Acids Research, 29(16):3347–3355, August 2001. URL: http://dx.doi.org/10.1093/nar/29.16.3347, doi:10.1093/nar/29.16.3347. This article has 58 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/29.16.3347)

[11. (Li2022Clinical) Yan Li, Duanfeng Jiang, Qin Zhang, Enyi Liu, and Haigang Shao. Clinical implications and genetical insights of sox6 expression in acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology, 149(8):4443–4453, September 2022. URL: http://dx.doi.org/10.1007/s00432-022-04349-8, doi:10.1007/s00432-022-04349-8. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-022-04349-8)

[12. (Yamashita2000Characterization) Atsushi Yamashita, Michihiko Ito, Nobuhiko Takamatsu, and Tadayoshi Shiba. Characterization of solt, a novel soxlz/sox6 binding protein expressed in adult mouse testis. FEBS Letters, 481(2):147–151, September 2000. URL: http://dx.doi.org/10.1016/s0014-5793(00)01987-6, doi:10.1016/s0014-5793(00)01987-6. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-5793(00)01987-6)